Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
61
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
33
users have liked this narrative
6
users have commented on this narrative
89
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Destination XL Group
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Margins And Traffic Will Limit Sales But Ecommerce Will Rise
Key Takeaways Reliance on brick-and-mortar stores and exposure to discount-driven competitors threatens margin stability and limits the effectiveness of digital and private label initiatives. Evolving consumer health trends and increased adoption of weight-loss solutions could shrink the core customer base, challenging long-term growth prospects.
View narrative
US$1.30
FV
7.7% undervalued
intrinsic discount
3.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
23 days ago
author updated this narrative
OraSure Technologies
AN
AnalystLowTarget
Consensus Narrative from 1 Analyst
Diagnostics Will Face Funding Cuts Yet Show Signs Of Resilience
Key Takeaways Reliance on government funding and major clients creates revenue volatility, while rising compliance costs and regulatory demands threaten profitability and slow innovation. Intensifying competition and shifts toward digital health and telemedicine risk eroding market relevance, compressing margins, and hampering long-term growth prospects.
View narrative
US$5.00
FV
44.4% undervalued
intrinsic discount
-3.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Holley
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Electric Vehicle Expansion Will Undermine Combustion Engines But Offer Hope
Key Takeaways The shift toward electric vehicles and changing consumer preferences threaten long-term demand and market size for Holley's traditional performance products. Regulatory pressures and economic uncertainty could undermine profitability and render key products less viable, increasing revenue and earnings volatility.
View narrative
US$2.25
FV
39.6% overvalued
intrinsic discount
4.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
TTI
TETRA Technologies
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Deepwater And Desalination Risks Will Stall Plans Yet Hope Emerges
Key Takeaways Growth in water management and chemical sales depends on uncertain adoption timing, partner performance, and regulatory shifts, which could delay or limit margin expansion. Revenue streams from lithium extraction and offshore fluids are promising but exposed to technology, market trends, and project timing risks, impacting earnings consistency.
View narrative
US$4.00
FV
2.0% undervalued
intrinsic discount
1.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Designer Brands
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Weak Consumer Demand And Margin Strain Will Spur Emerging Value
Key Takeaways Expansion of owned brands and private labels boosts margins, but weak consumer demand and declining store traffic undermine sustainable revenue growth. Digital investments help retention, yet heavy reliance on promotions, limited pricing power, and a burdensome retail footprint pressure margins and earnings.
View narrative
US$3.00
FV
3.0% undervalued
intrinsic discount
0.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Dave
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Regulatory Scrutiny And Competition Will Derail Digital Banking Prospects
Key Takeaways Heightened regulatory scrutiny and increased competition threaten to constrain Dave's growth, compress margins, and erode its pricing power and differentiation. Dependence on paid marketing, economic sensitivity of core users, and rising acquisition costs could lead to lower profitability and difficulties sustaining membership growth.
View narrative
US$177.00
FV
3.4% overvalued
intrinsic discount
21.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
American Axle & Manufacturing Holdings
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Legacy Driveline Demand Will Decline Despite Reshoring Benefits
Key Takeaways The shift to electric vehicles threatens key revenue streams and increases competitive pressure, challenging the company’s ability to adapt and maintain profitability. Dependence on major automakers and high debt levels raise financial risk, especially amid costly investment needs and uncertain EV market adoption.
View narrative
US$4.00
FV
32.0% overvalued
intrinsic discount
-1.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Ironwood Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Regulatory Delays And Pricing Headwinds Will Impede Performance But Stabilize
Key Takeaways Heavy reliance on new drug approvals and reimbursement stability exposes future revenues and margins to regulatory, market, and policy uncertainties. Growth opportunities from pipeline diversification are limited by small target markets and potential slow uptake, posing risk to sustained earnings expansion.
View narrative
US$0.70
FV
28.1% overvalued
intrinsic discount
-19.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Limbach Holdings
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Modular Adoption And Rising Costs Will Weaken Construction Margins
Key Takeaways Rapid shifts toward modular construction and digitalization threaten Limbach's core business and could erode competitiveness and margins against more technologically advanced peers. Heavy reliance on healthcare and institutional clients, coupled with rising costs and macroeconomic pressures, increases vulnerability to sector downturns and earnings volatility.
View narrative
US$120.00
FV
4.7% undervalued
intrinsic discount
18.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Value any company in seconds
Popular companies